Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Medication Use for Opioid Use Disorder

Ann Intern Med; ePub 2018 Jun 19; Larochelle, et al

Only a minority of opioid overdose survivors received medications for opioid use disorder (MOUD) after nonfatal overdose, with buprenorphine and methadone maintenance treatment (MMT) associated with reduced all-cause and opioid-related mortality. This according to a recent retrospective cohort study that included 17,568 adults from Massachusetts without cancer who survived an opioid overdose between 2012 and 2014. 3 types of MOUD were examined: MMT, buprenorphine, and naltrexone. Exposure to MOUD was identified at monthly intervals, and persons were considered exposed through the month after last receipt. Researchers found:

  • In the 12 months after a nonfatal overdose, 2,040 persons (11%) enrolled in MMT for a median of 5 months, 3,022 persons (17%) received buprenorphine for a median of 4 months, and 1,099 persons (6%) received naltrexone for a median of 1 month.
  • All-cause mortality was 4.7 deaths per 100 person-years among the entire cohort, and opioid-related mortality was 2.1 deaths per 100 person-years.
  • Buprenorphine and MMT were associated with reduced all-cause and opioid-related mortality.
  • There were no associations between naltrexone and all-cause mortality or opioid-related mortality.

Citation:

Larochelle MR, Bernson D, Land T, et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: A cohort study. [Published online ahead of print June 19, 2018]. Ann Intern Med. doi:10.7326/M17-3107.

This Week's Must Reads

Screening for Syphilis Infection in Pregnant Women, JAMA; 2018 Sep 4; US Preventive Services Task Force

Treatment Intensification Guidelines for T2D , Ann Intern Med; ePub 2018 Sep 4; Roglic, et al

Immediate vs Gradual Nicotine Reduction in Cigarettes, JAMA; ePub 2018 Sep 4; Hatsukami, et al

Prevalence of Diabetes Among US Adults, BMJ; ePub 2018 Aug 27; Xu, Liu, et al

Effect of Fish Oil Supplementation in Pregnancy, BMJ; ePub 2018 Sep 4; Vinding, Stokholm, et al

Must Reads in Addiction Medicine

Immediate vs Gradual Nicotine Reduction in Cigarettes, JAMA; ePub 2018 Sep 4; Hatsukami, et al

Alcohol Use and Global Disease Burden, Lancet; ePub 2018 Aug 23; GBD 2016 Alcohol Collaborators

Risks and Benefits of Marijuana Use, Ann Intern Med; ePub 2018 Jul 24; Keyhani, et al

Medication Use for Opioid Use Disorder, Ann Intern Med; ePub 2018 Jun 19; Larochelle, et al

Do Smoking Cessation Incentives Aid in Abstinence?, N Engl J Med; 2018 Jun 14; Halpern, et al